These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8362384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Nausea and vomiting in oncologic therapy. Guidelines for use of setrone].
    Nemec K.
    Pharm Unserer Zeit; 2007; 36(5):362-7. PubMed ID: 17722163
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS.
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K, Voigt W, Schmoll HJ.
    Dtsch Med Wochenschr; 2006 Aug 25; 131(34-35):1869-72. PubMed ID: 16915549
    [Abstract] [Full Text] [Related]

  • 9. [The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].
    Perevodchikova NI, Volkova MA, Gorbunova VA, Manziuk LV, Marenich AF, Smirnova NB.
    Ter Arkh; 1996 Aug 25; 68(2):30-4. PubMed ID: 8771653
    [Abstract] [Full Text] [Related]

  • 10. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents].
    Tong FZ, Zhang JQ, Qiao XM, Mao YC, Meng FY, Liu HJ, Hui S, Zhu FX, Shu W, Hong J.
    Gan To Kagaku Ryoho; 1998 Feb 25; 25(3):391-5. PubMed ID: 9492833
    [Abstract] [Full Text] [Related]

  • 11. Nabilone (Cesamet) for chemotherapy-induced nausea and vomiting.
    Med Lett Drugs Ther; 2006 Dec 04; 48(1249/1250):103-4. PubMed ID: 17149361
    [No Abstract] [Full Text] [Related]

  • 12. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG, Berglind AM, Andersson H, Boman K, Högberg T, Hallgren M, Schmidt M.
    Cancer; 1998 Sep 01; 83(5):1022-32. PubMed ID: 9731907
    [Abstract] [Full Text] [Related]

  • 13. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U, Drechsler S, Eggert J, Gosse H, Ukena D, Imhoff W, Faerber L.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [Abstract] [Full Text] [Related]

  • 14. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
    Hartvig P.
    J Oncol Pharm Pract; 2007 Mar 01; 13(1):57-8. PubMed ID: 17621570
    [No Abstract] [Full Text] [Related]

  • 15. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 01; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 16. [Navoban--the new 5HT3-antagonist].
    Internist (Berl); 1994 May 01; 35(5 Suppl):1-8. PubMed ID: 9209536
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB.
    Clin Adv Hematol Oncol; 2004 May 01; 2(5):284-9. PubMed ID: 16163194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.